DE69826851D1 - Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen - Google Patents
Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffenInfo
- Publication number
- DE69826851D1 DE69826851D1 DE69826851T DE69826851T DE69826851D1 DE 69826851 D1 DE69826851 D1 DE 69826851D1 DE 69826851 T DE69826851 T DE 69826851T DE 69826851 T DE69826851 T DE 69826851T DE 69826851 D1 DE69826851 D1 DE 69826851D1
- Authority
- DE
- Germany
- Prior art keywords
- haloacyl
- protein
- polysaccharide
- moiety
- vaccints
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4237997P | 1997-04-24 | 1997-04-24 | |
US42379P | 1997-04-24 | ||
PCT/US1998/008138 WO1998047530A2 (en) | 1997-04-24 | 1998-04-23 | Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69826851D1 true DE69826851D1 (de) | 2004-11-11 |
DE69826851T2 DE69826851T2 (de) | 2005-02-10 |
Family
ID=21921604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69826851T Expired - Fee Related DE69826851T2 (de) | 1997-04-24 | 1998-04-23 | Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6087328A (de) |
EP (1) | EP0977588B1 (de) |
JP (1) | JP2002504096A (de) |
AT (1) | ATE278418T1 (de) |
AU (1) | AU740784B2 (de) |
CA (1) | CA2288267A1 (de) |
DE (1) | DE69826851T2 (de) |
ES (1) | ES2230687T3 (de) |
WO (1) | WO1998047530A2 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248334B1 (en) | 1997-01-08 | 2001-06-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
HU230490B1 (hu) | 2001-01-23 | 2016-08-29 | Sanofi Pasteur Inc. | Multivalens, meningokokkusz-eredetű poliszaccharid és fehérje konjugátumát tartalmazó vakcina |
GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
WO2005054493A2 (en) * | 2003-06-12 | 2005-06-16 | Mayo Foundation For Medical Education And Research | Altered activity of toll-like receptors |
JP2007519746A (ja) * | 2004-01-29 | 2007-07-19 | バイオシネクサス インコーポレーティッド | ワクチン調製におけるアミノ−オキシ官能基の使用 |
US10828361B2 (en) | 2006-03-22 | 2020-11-10 | Glaxosmithkline Biologicals Sa | Regimens for immunisation with meningococcal conjugates |
AU2007229449A1 (en) | 2006-03-22 | 2007-10-04 | Novartis Ag | Regimens for immunisation with meningococcal conjugates |
US8647621B2 (en) | 2009-07-27 | 2014-02-11 | Fina Biosolutions, Llc | Method of producing protein-carbohydrate vaccines reduced in free carbohydrate |
EP2513056B1 (de) | 2009-12-17 | 2022-05-04 | Serum Institute of India Pvt. Ltd. | Chemische reagenzien zur aktivierung von polysacchariden bei der herstellung von konjugatimpfstoffen |
ES2743156T3 (es) | 2010-04-23 | 2020-02-18 | Serum Institute Of India Pvt Ltd | Método simple para eliminación simultánea de múltiples impurezas a partir de sobrenadantes de cultivo a niveles ultrabajos |
BR112013028892B1 (pt) * | 2011-05-11 | 2021-06-15 | Children's Medical Center Corporation | Proteína de ligação à biotina modificada, proteínas de fusão da mesma e aplicações |
TR201909110T4 (tr) | 2011-09-14 | 2019-07-22 | Glaxosmithkline Biologicals Sa | Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler. |
WO2014124228A1 (en) | 2013-02-07 | 2014-08-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
AU2016429272A1 (en) * | 2016-11-14 | 2019-05-02 | Hangzhou Dac Biotech Co., Ltd. | Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
WO2018183475A1 (en) | 2017-03-28 | 2018-10-04 | Children's Medical Center Corporation | A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof |
SG11201912601RA (en) | 2017-06-23 | 2020-01-30 | Nosocomial Vaccine Corp | Immunogenic compositions |
WO2019074110A1 (ja) * | 2017-10-13 | 2019-04-18 | 株式会社ボナック | 一本鎖核酸分子およびその製造方法 |
WO2020056202A1 (en) | 2018-09-12 | 2020-03-19 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
AU2022342080A1 (en) | 2021-09-09 | 2024-03-28 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3278392A (en) * | 1962-11-12 | 1966-10-11 | Yeda Res & Dev | Water insoluble enzymes |
US3816254A (en) * | 1970-02-03 | 1974-06-11 | Tanabe Seiyaku Co | Optical resolution of racemic amino acids |
US4185090A (en) * | 1972-02-02 | 1980-01-22 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
US4328311A (en) * | 1978-02-10 | 1982-05-04 | Syva Company | Enzyme-aminoglycoside conjugates |
US4695624A (en) * | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
NZ214503A (en) * | 1984-12-20 | 1990-02-26 | Merck & Co Inc | Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
US5204098A (en) * | 1988-02-16 | 1993-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-protein conjugates |
US5445817A (en) * | 1992-08-21 | 1995-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
JP3828145B2 (ja) * | 1993-09-22 | 2006-10-04 | ヘンリー エム.ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 免疫原性構成物の製造のための新規シアン化試薬を使った可溶性炭水化物の活性化方法 |
US5565204A (en) * | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
CA2215933C (en) * | 1995-03-22 | 2009-10-13 | Andrew Lees | Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
-
1998
- 1998-04-23 CA CA002288267A patent/CA2288267A1/en not_active Abandoned
- 1998-04-23 EP EP98918592A patent/EP0977588B1/de not_active Expired - Lifetime
- 1998-04-23 AT AT98918592T patent/ATE278418T1/de not_active IP Right Cessation
- 1998-04-23 WO PCT/US1998/008138 patent/WO1998047530A2/en active IP Right Grant
- 1998-04-23 US US09/064,827 patent/US6087328A/en not_active Expired - Fee Related
- 1998-04-23 ES ES98918592T patent/ES2230687T3/es not_active Expired - Lifetime
- 1998-04-23 AU AU71491/98A patent/AU740784B2/en not_active Ceased
- 1998-04-23 DE DE69826851T patent/DE69826851T2/de not_active Expired - Fee Related
- 1998-04-23 JP JP54631698A patent/JP2002504096A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2002504096A (ja) | 2002-02-05 |
DE69826851T2 (de) | 2005-02-10 |
AU740784B2 (en) | 2001-11-15 |
EP0977588B1 (de) | 2004-10-06 |
US6087328A (en) | 2000-07-11 |
CA2288267A1 (en) | 1998-10-29 |
WO1998047530A3 (en) | 1999-01-28 |
EP0977588A2 (de) | 2000-02-09 |
ATE278418T1 (de) | 2004-10-15 |
ES2230687T3 (es) | 2005-05-01 |
WO1998047530A2 (en) | 1998-10-29 |
AU7149198A (en) | 1998-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69826851D1 (de) | Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen | |
DK171951B1 (da) | Fremgangsmaade til solubilisering af ikke-polyanioniske polysaccharider og fremgangsmaade til modificering af de solubiliserede neutrale polysaccharider | |
ES2346022T3 (es) | Procedimiento para la extraccion y el aislamiento de polisacaridos capsulares bacterianos para su uso como vacunas o ligandos a proteinas como vacunas de conjugados. | |
DE122009000058I1 (de) | Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten | |
DK205585D0 (da) | Polysaccharidproteinkonjugat, fremgangsmaade til fremstilling deraf ogpraeparat omfattende et polysaccharidproteinkonjugat | |
ES2154263T3 (es) | Vacuna a base de conjugados de o-polisacarido-proteina de escherichia coli. | |
PT76394A (fr) | Procede de preparation de nouveaux conjugues associant par liaison covalente une enzyme et un anticorps | |
AU3722093A (en) | Dual carrier immunogenic construct | |
ATE19734T1 (de) | Heamophilus influenzae b polysaccharid exotoxoid konjugat-impfstoff. | |
Lambden et al. | Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolyasaccharide of Neisseria Gonorrhoeae P9 | |
DK0450628T3 (da) | Saccharidmidificerede, vandopløselæige proteiner | |
EP0747063A3 (de) | Konjugate von Neisseria Meningitidis Kapselpolysacchariden | |
AU3313789A (en) | Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine | |
EP0894008A1 (de) | Verfahren zur herstellung von immunoaktiven mittel und impfstoffe | |
US5142027A (en) | Cationized carriers for immunogen production | |
Mowat et al. | Preparation of Immune Stimulating Complexes (ISCOM s) as Adjuvants | |
DE4122906A1 (de) | Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung | |
JP2000191693A (ja) | 抗原の可溶化法及び該方法により得られた可溶化抗原 | |
ATE59856T1 (de) | Sor-genprodukt von lymphotropem virus-iii menschlicher t-zellen. | |
NO157603B (no) | Fremgangsmÿte for fremstilling av et vannopplelig kovale nt polysakkarid difteri/toksoid konjugat samt et hapten, i det vesentlige fritt for protein og nukleinsyre. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |